RAD51 and breast carcinoma: Immunohistochemistry of RAD51 foci was demonstrated in formalin-fixed paraffin-embedded (FFPE) samples of breast cancer, and positive RAD51 foci correlated with resistance to platinum or PARPi (110, 124, 134).